Sagimet Biosciences Files 8-K

Ticker: SGMT · Form: 8-K · Filed: Mar 11, 2025 · CIK: 1400118

Sentiment: neutral

Topics: 8-K, corporate-filing, financials

TL;DR

Sagimet Biosciences filed an 8-K on 3/11/25. Routine update.

AI Summary

Sagimet Biosciences Inc. filed an 8-K on March 11, 2025, reporting other events and financial statements. The company, formerly known as 3-V Biosciences, Inc., is incorporated in Delaware and headquartered in San Mateo, California.

Why It Matters

This filing indicates routine corporate reporting, providing updates on events and financial statements for Sagimet Biosciences Inc.

Risk Assessment

Risk Level: low — This is a standard 8-K filing for corporate reporting and does not appear to contain significant new risks.

Key Numbers

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing?

The primary purpose of this 8-K filing is to report 'Other Events' and 'Financial Statements and Exhibits' as of March 11, 2025.

When was the earliest event reported in this filing?

The earliest event reported in this filing was on March 11, 2025.

What was Sagimet Biosciences Inc. formerly known as?

Sagimet Biosciences Inc. was formerly known as 3-V Biosciences, Inc.

Where are Sagimet Biosciences Inc.'s principal executive offices located?

Sagimet Biosciences Inc.'s principal executive offices are located at 155 Bovet Road, Suite 303, San Mateo, California 94402.

What is the company's state of incorporation?

The company's state of incorporation is Delaware.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on March 11, 2025 regarding Sagimet Biosciences Inc. (SGMT).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing